The Female Infertility Hormone Panel is commonly used to aid in the diagnosis and evaluation of various conditions related to female reproductive health and fertility challenges, including:

• Primary and Secondary Infertility: Investigating underlying hormonal causes when conception is difficult.
• Ovulatory Dysfunction and Anovulation: Identifying irregularities in ovulation that prevent successful conception, often linked to imbalances in FSH, LH, and Progesterone.
• Polycystic Ovary Syndrome (PCOS): Assisting in the diagnosis and monitoring of PCOS, which often involves hormonal imbalances, irregular periods, and difficulty conceiving. Key indicators include elevated LH:FSH ratio, altered Progesterone, and sometimes elevated Prolactin.
• Diminished Ovarian Reserve: Assessing the quantity and quality of remaining eggs, primarily through AMH levels, to predict ovarian response to fertility treatments.
• Luteal Phase Defects: Evaluating the adequacy of progesterone production after ovulation, which is crucial for endometrial preparation and maintaining early pregnancy.
• Hyperprolactinemia: Diagnosing elevated prolactin levels that can interfere with ovulation and lead to amenorrhea (absence of menstruation) or galactorrhea (inappropriate lactation).
• Thyroid Disorders Impacting Fertility: Identifying both hypothyroidism and hyperthyroidism, as thyroid dysfunction can significantly affect menstrual cycle regularity, ovulation, and increase the risk of miscarriage.
• Irregular Menstrual Cycles: Pinpointing hormonal causes behind amenorrhea, oligomenorrhea, or dysfunctional uterine bleeding.
• Recurrent Pregnancy Loss: Investigating hormonal imbalances that might contribute to repeated miscarriages.

This comprehensive panel helps clinicians develop a targeted treatment plan to address specific hormonal imbalances and improve fertility outcomes.